Concepedia

Patrick Schweigler

PS

5

Publications

270

Citations

5

H-Index

2008

Active since

Affiliations

Novartis Institutes for BioMedical Research(Current)

Novartis (Switzerland)

Patrick Schweigler is an author at Novartis Institutes for BioMedical Research specializing in drug discovery, medicine, and biochemistry.

Top concepts

Publications per year

2008–2019

5

Publications

5

The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling

Théo Klein, Shan‐Yu Fung, Florian Renner et al. · Nature Communications · 2015 · 147 citations · Full text

A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters

Péter Tátrai, Patrick Schweigler, Birk Poller et al. · Drug Metabolism and Disposition · 2019 · 56 citations · Full text

In-cell Selectivity Profiling of Serine Protease Inhibitors by Activity-based Proteomics

Ludovic Gillet, Kenji Namoto, Alexandra Ruchti et al. · Molecular & Cellular Proteomics · 2008 · 43 citations · Full text

, , +17

Fragment‐Based Protein–Protein Interaction Antagonists of a Viral Dimeric Protease

Jonathan E. Gable, Gregory M. Lee, Timothy M. Acker et al. · ChemMedChem · 2016 · 12 citations · Full text

Examining P-gp efflux kinetics guided by the BDDCS – Rational selection of in vitro assay designs and mathematical models

Julia Riede, Kenichi Umehara, Patrick Schweigler et al. · European Journal of Pharmaceutical Sciences · 2019 · 12 citations

, , +10

Rows per page

1–5 of 5